2021 Report on Corneal Neovascularization Drugs In Development – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Corneal Neovascularization (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Corneal Neovascularization (Ophthalmology) pipeline landscape. Corneal neovascularization is a corneal condition where oxygen deprivation and stress cause abnormal blood vessels to grow in the normally clear, translucent cornea. Predisposing factors include infections, trauma to the eye, chemica